Director Deals - Shield Therapeutics PLC (STX)

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Timothy Watts, Chief Executive Officer, exercised 100,000 shares in the company on the 18th December 2020 at a price of £0.02. The Director now holds 648,700 shares.

Director deals data provided by www.sharesmagazine.co.uk